Cipla arm acquires US-based Avenue Therapeutics
Cipla arm acquires US-based Avenue Therapeutics

Cipla arm acquires US-based Avenue Therapeutics

Shohini Nath Article rating: 5.0

InvaGen Pharmaceuticals, a subsidiary of pharma major Cipla, is set to acquire Avenue Therapeutics, a NASDAQ listed pharmaceutical company. The shares of Cipla, however, were trading marginally down at 0.54 per cent in the morning trading session.

Ten stocks close to their 52-week high
Ten stocks close to their 52-week high

Ten stocks close to their 52-week high

Shital Jibhe Article rating: 2.5

The markets on November 13, 2018 opened gap down. BSE Sensex is trading at 34,872.89, up by 59.90 points and the Nifty is trading at 10,505.45, up by 23.25 points. 

Tata Motors: Jaguar Land Rover wholesale numbers show growth
Tata Motors: Jaguar Land Rover wholesale numbers show growth

Tata Motors: Jaguar Land Rover wholesale numbers show growth

Gayathri Udyawar Article rating: 3.3

The company's premium range of cars, which contribute majorly to its revenues, registered a 6 per cent YoY growth in October 2018, said a company release reporting Tata Motor's global wholesale figures.

Five stocks with selling interest
Five stocks with selling interest

Five stocks with selling interest

Shital Jibhe Article rating: 5.0

Overall volumes in futures & options currently stand at 1.00 crore contracts with a turnover of Rs. 5,71,569.46 crore.

Five stocks with buying interest
Five stocks with buying interest

Five stocks with buying interest

Shital Jibhe Article rating: 5.0

Overall volumes in futures & options currently stand at 1.00 crore contracts with a turnover of Rs. 5,71,569.46 crore.

Index trend and stocks in action November 13, 2018
Index trend and stocks in action November 13, 2018

Index trend and stocks in action November 13, 2018

Karan Dsij Article rating: 5.0

Going ahead, there is a high probability of the weakness persisting in the index. Immediate support for the index is placed in the region of 10,442-10,458 which is the gap area formed on November 2. Stocks in news: HCL Technologies, NBCC, Lupin, TVS Motor, Aurobindo Pharma, Piramal Enterprises and Tata Motors.

Negative opening likely following weak global cues
Negative opening likely following weak global cues

Negative opening likely following weak global cues

Karan Dsij Article rating: 4.0

Indian stocks look set to open lower on Tuesday mirroring weak cues from the Wall Street overnight and sell-off seen in the Asian markets. The SGX Nifty Index Future, which was down by 50 points, indicates Nifty may open around the level of 10,450. 

Quarterly Results to watch out on November 13
Quarterly Results to watch out on November 13

Quarterly Results to watch out on November 13

Shohini Nath Article rating: 3.5

The following stocks could be in focus in Tuesday’s trading session in light of their results: Apollo Tyres, Ashok Leyland, CG Power, Deepak Fertilizer and Glenmark Pharmaceuticals.

Overnight Digest: Stocks to watch out for on November 13
Overnight Digest: Stocks to watch out for on November 13

Overnight Digest: Stocks to watch out for on November 13

Dnyanada Kulkarni Article rating: 3.7

The stocks most likely to witness significant movement on the bourses on November 13 are Tide Water Oil Co. (India) Ltd., Dredging Corporation of India, HCL Technologies Ltd., Britannia Industries Ltd., and Kilitch Drugs (India) Ltd.

RSS
First31453146314731483150315231533154Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR